• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型胍类化合物的抗贾第虫活性。

Antigiardial Activity of Novel Guanidine Compounds.

机构信息

School of Environmental & Life Sciences, The University of Newcastle, University Drive, Callaghan, NSW 2308, Australia.

Antimicrobial resistance and Infectious Diseases Laboratory, Harry butler Institute, Murdoch University, 90 South Street, Murdoch, WA 6150, Australia.

出版信息

ChemMedChem. 2022 Nov 4;17(21):e202200341. doi: 10.1002/cmdc.202200341. Epub 2022 Sep 29.

DOI:10.1002/cmdc.202200341
PMID:36085254
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9828538/
Abstract

From four focused compound libraries based on the known anticoccidial agent robenidine, 44 compounds total were synthesised and screened for antigiardial activity. All active compounds were counter-screened for antibiotic and cytotoxic action. Of the analogues examined, 21 displayed IC <5 μM, seven with IC <1.0 μM. Most active were 2,2'-bis{[4-(trifluoromethoxy)phenyl]methylene}carbonimidic dihydrazide hydrochloride (30), 2,2'-bis{[4-(trifluoromethylsulfanyl)phenyl]methylene}carbonimidic dihydrazide hydrochloride (32), and 2,2'-bis[(2-bromo-4,5-dimethoxyphenyl)methylene]carbonimidic dihydrazide hydrochloride (41) with IC =0.2 μM. The maximal observed activity was a 5 h IC value of 0.2 μM for 41. The clinically used metronidazole was inactive at this timepoint at a concentration of 25 μM. Robenidine off-target effects at bacteria and cell line toxicity were removed. Analogue 41 was well tolerated in mice treated orally (100 mg/kg). Following 5 h treatment with 41, no Giardia regrowth was noted after 48 h.

摘要

从四个基于已知抗球虫药罗贝林的靶向化合物库中,共合成了 44 种化合物并对其抗贾第虫活性进行了筛选。所有活性化合物均进行了抗生素和细胞毒性的反向筛选。在所检查的类似物中,有 21 种的 IC <5 μM,其中 7 种的 IC <1.0 μM。最活跃的是 2,2'-双{[4-(三氟甲氧基)苯基]亚甲基}碳二亚胺二盐酸盐(30)、2,2'-双{[4-(三氟甲基硫基)苯基]亚甲基}碳二亚胺二盐酸盐(32)和 2,2'-双[(2-溴-4,5-二甲氧基苯基)亚甲基]碳二亚胺二盐酸盐(41),IC =0.2 μM。观察到的最大活性是 41 的 5 h IC 值为 0.2 μM。此时,临床使用的甲硝唑在 25 μM 浓度下无活性。罗贝林对细菌的脱靶效应和细胞系毒性已被消除。类似物 41 在经口给药的小鼠中耐受性良好(100 mg/kg)。用 41 处理 5 小时后,48 小时后未观察到贾第虫再生长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6c/9828538/66d776a3c9d6/CMDC-17-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6c/9828538/7dc607364c86/CMDC-17-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6c/9828538/de6e7c013028/CMDC-17-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6c/9828538/66d776a3c9d6/CMDC-17-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6c/9828538/7dc607364c86/CMDC-17-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6c/9828538/de6e7c013028/CMDC-17-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6c/9828538/66d776a3c9d6/CMDC-17-0-g001.jpg

相似文献

1
Antigiardial Activity of Novel Guanidine Compounds.新型胍类化合物的抗贾第虫活性。
ChemMedChem. 2022 Nov 4;17(21):e202200341. doi: 10.1002/cmdc.202200341. Epub 2022 Sep 29.
2
Robenidine Analogues as Gram-Positive Antibacterial Agents.罗贝林类似物作为革兰氏阳性抗菌剂。
J Med Chem. 2016 Mar 10;59(5):2126-38. doi: 10.1021/acs.jmedchem.5b01797. Epub 2016 Feb 10.
3
Robenidine derivatives as potential antischistosomal drug candidates.作为潜在抗血吸虫病候选药物的罗贝尼丁衍生物。
Int J Parasitol Drugs Drug Resist. 2024 Aug;25:100546. doi: 10.1016/j.ijpddr.2024.100546. Epub 2024 May 5.
4
Absorption, excretion, and metabolism of 1,3-bis(p-chlorobenzylideneamino)guanidine hydrochloride (Robenz robenidine hydrochloride) in the chicken.1,3-双(对氯亚苄基氨基)胍盐酸盐(盐酸氯苯胍)在鸡体内的吸收、排泄及代谢
J Agric Food Chem. 1975 Jul-Aug;23(4):724-30. doi: 10.1021/jf60200a049.
5
Gram-Positive and Gram-Negative Antibiotic Activity of Asymmetric and Monomeric Robenidine Analogues.不对称和单体罗布麻碱类似物的革兰氏阳性和革兰氏阴性抗生素活性。
ChemMedChem. 2018 Dec 6;13(23):2573-2580. doi: 10.1002/cmdc.201800463. Epub 2018 Nov 19.
6
Absorption, excretion, and metabolism of robenz, robenidine hydrochloride (1,3-bis(p-chlorobenzylideneamino)guanidine hydrochloride), in the rat.盐酸氯苯胍(1,3 - 双(对氯亚苄基氨基)胍盐酸盐)在大鼠体内的吸收、排泄及代谢
J Agric Food Chem. 1973 Sep-Oct;21(5):794-7. doi: 10.1021/jf60189a011.
7
Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent.罗贝尼丁类似物NCL195作为新型广谱抗菌剂的评估。
PLoS One. 2017 Sep 5;12(9):e0183457. doi: 10.1371/journal.pone.0183457. eCollection 2017.
8
Eimeria tenella: experimental studies on the development of resistance to robenidine.柔嫩艾美耳球虫:对罗苯哒唑耐药性发展的实验研究
Parasitology. 1976 Dec;73(3):265-73. doi: 10.1017/s0031182000046953.
9
Polarographic determination of robenidine residues in chicken tissues, eggs, litter, soil, and plant tissue.极谱法测定鸡组织、鸡蛋、垫料、土壤和植物组织中的罗苯尼丁残留量。
J Assoc Off Anal Chem. 1977 Nov;60(6):1310-7.
10
Chemotherapy of experimental toxoplasmosis with special reference to robenidine.实验性弓形虫病的化疗,特别提及罗苯尼丁。
Folia Parasitol (Praha). 1988;35(3):193-8.

引用本文的文献

1
Superior Anticancer and Antifungal Activities of New Sulfanyl-Substituted Niclosamide Derivatives.新型硫烷基取代氯硝柳胺衍生物的卓越抗癌和抗真菌活性
Biomedicines. 2024 Jul 21;12(7):1621. doi: 10.3390/biomedicines12071621.
2
Ultrastructural Alterations of the Human Pathogen after Drug Treatment.药物治疗后人类病原体的超微结构改变
Pathogens. 2023 Jun 7;12(6):810. doi: 10.3390/pathogens12060810.

本文引用的文献

1
Comparison of Two Transmission Electron Microscopy Methods to Visualize Drug-Induced Alterations of Gram-Negative Bacterial Morphology.两种透射电子显微镜方法用于观察革兰氏阴性菌形态学药物诱导变化的比较
Antibiotics (Basel). 2021 Mar 17;10(3):307. doi: 10.3390/antibiotics10030307.
2
Activity of Robenidine Analog NCL195 in Combination With Outer Membrane Permeabilizers Against Gram-Negative Bacterial Pathogens and Impact on Systemic Gram-Positive Bacterial Infection in Mice.罗贝尼定类似物NCL195与外膜通透剂联合对革兰氏阴性菌病原体的活性及对小鼠全身性革兰氏阳性菌感染的影响
Front Microbiol. 2020 Aug 4;11:1556. doi: 10.3389/fmicb.2020.01556. eCollection 2020.
3
Drug resistance in Giardia: Mechanisms and alternative treatments for Giardiasis.
贾第虫耐药性:贾第虫病的机制和替代治疗方法。
Adv Parasitol. 2020;107:201-282. doi: 10.1016/bs.apar.2019.11.003. Epub 2020 Jan 17.
4
Aminoguanidines: New leads for treatment of Giardia duodenalis infection.氨胍类药物:治疗十二指肠贾第鞭毛虫感染的新线索。
Int J Parasitol Drugs Drug Resist. 2019 Aug;10:38-44. doi: 10.1016/j.ijpddr.2019.04.003. Epub 2019 Apr 8.
5
Redox Pathways as Drug Targets in Microaerophilic Parasites.氧化还原途径作为微需氧寄生虫的药物靶点。
Trends Parasitol. 2018 Jul;34(7):576-589. doi: 10.1016/j.pt.2018.04.007. Epub 2018 May 26.
6
Giardia duodenalis mouse model for the development of novel antigiardial agents.用于新型抗贾第鞭毛虫药物研发的十二指肠贾第鞭毛虫小鼠模型
J Microbiol Methods. 2018 Feb;145:7-9. doi: 10.1016/j.mimet.2017.11.025. Epub 2017 Dec 1.
7
Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent.罗贝尼丁类似物NCL195作为新型广谱抗菌剂的评估。
PLoS One. 2017 Sep 5;12(9):e0183457. doi: 10.1371/journal.pone.0183457. eCollection 2017.
8
Identification and Validation of Small-Gatekeeper Kinases as Drug Targets in Giardia lamblia.鉴定和验证小守门激酶作为蓝氏贾第鞭毛虫的药物靶点
PLoS Negl Trop Dis. 2016 Nov 2;10(11):e0005107. doi: 10.1371/journal.pntd.0005107. eCollection 2016 Nov.
9
Robenidine Analogues as Gram-Positive Antibacterial Agents.罗贝林类似物作为革兰氏阳性抗菌剂。
J Med Chem. 2016 Mar 10;59(5):2126-38. doi: 10.1021/acs.jmedchem.5b01797. Epub 2016 Feb 10.
10
Drug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and Giardia.针对引起腹泻的小肠主要寄生虫隐孢子虫和贾第鞭毛虫的药物研发
Front Microbiol. 2015 Nov 19;6:1208. doi: 10.3389/fmicb.2015.01208. eCollection 2015.